IC

Ikarian Capital Portfolio holdings

AUM $302M
This Quarter Return
-1.15%
1 Year Return
+65.21%
3 Year Return
+441.33%
5 Year Return
+548.26%
10 Year Return
–
AUM
$320M
AUM Growth
+$320M
Cap. Flow
+$6.14M
Cap. Flow %
1.92%
Top 10 Hldgs %
52.44%
Holding
116
New
16
Increased
13
Reduced
23
Closed
13

Top Buys

1
ELVN icon
Enliven Therapeutics
ELVN
$13.7M
2
AMGN icon
Amgen
AMGN
$12M
3
SRPT icon
Sarepta Therapeutics
SRPT
$8.11M
4
VKTX icon
Viking Therapeutics
VKTX
$7.33M
5
RNAC icon
Cartesian Therapeutics
RNAC
$6.55M

Top Sells

1
CRBP icon
Corbus Pharmaceuticals
CRBP
$11.3M
2
ALPN
Alpine Immune Sciences, Inc. Common Stock
ALPN
$10.4M
3
PRAX icon
Praxis Precision Medicines
PRAX
$10.3M
4
ALNY icon
Alnylam Pharmaceuticals
ALNY
$7.7M
5
ANNX icon
Annexon
ANNX
$5.02M

Sector Composition

1 Healthcare 99.74%
2 Real Estate 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
IRON icon
101
Disc Medicine
IRON
$2.14B
– –
-25,372
Closed -$1.58M
KRYS icon
102
Krystal Biotech
KRYS
$4.35B
– –
0
– –
LNTH icon
103
Lantheus
LNTH
$3.75B
– –
0
– –
MDGL icon
104
Madrigal Pharmaceuticals
MDGL
$9.7B
– –
0
– –
MLTX icon
105
MoonLake Immunotherapeutics
MLTX
$3.78B
– –
0
– –
PRAX icon
106
Praxis Precision Medicines
PRAX
$980M
– –
-168,388
Closed -$10.3M
QURE icon
107
uniQure
QURE
$954M
– –
-469,133
Closed -$2.44M
SANA icon
108
Sana Biotechnology
SANA
$759M
– –
0
– –
TYRA icon
109
Tyra Biosciences
TYRA
$657M
– –
-501
Closed -$8.22K
VRDN icon
110
Viridian Therapeutics
VRDN
$1.59B
– –
0
– –
XBI icon
111
SPDR S&P Biotech ETF
XBI
$5.29B
– –
0
– –
GTHX
112
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
– –
0
– –
ASLN
113
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
– –
-35,420
Closed -$6.27K
ALPN
114
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
– –
-261,365
Closed -$10.4M
FNCH
115
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
– –
-6,892
Closed -$18.1K
LBPH
116
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
– –
-236
Closed -$5.1K
1 2 3 4
5